The Methodist Hospital Research Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction

Not Applicable

Completed

Conditions: ACL Tear

Interventions: Device: Blood flow restriction (BFR)

First Posted Date: 2020-07-24

Last Posted Date: 2024-11-25

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 50

Registration Number: NCT04484961

Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery

Not Applicable

Recruiting

Conditions: Limb Occlusion Pressure

Interventions: Device: Experimental - Limb Occlusion pressure

First Posted Date: 2020-05-15

Last Posted Date: 2024-10-18

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 400

Registration Number: NCT04390425

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Intraosseous Morphine in Primary TKA

Phase 4

Completed

Conditions: Knee Disease
Arthritis Knee
Pain, Acute

Interventions: Drug: Morphine

First Posted Date: 2020-05-14

Last Posted Date: 2021-07-07

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 48

Registration Number: NCT04388111

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Improving Adherence to Rabies PEP Guideline Recommendations

Not Applicable

Completed

Conditions: Rabies Virus Infection
Rabies
Rabies Human

Interventions: Other: Rabies PEP quality improvement bundle

First Posted Date: 2019-12-30

Last Posted Date: 2021-09-05

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 70

Registration Number: NCT04213950

Locations: 🇺🇸
Houston Methodist Hospital Emergency Department, Houston, Texas, United States
🇺🇸
Houston Methodist Emergency Care Center in Cypress, Cypress, Texas, United States
🇺🇸
Houston Methodist Emergency Care Center in Pearland, Pearland, Texas, United States

and more 12 locations

Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse

Not Applicable

Conditions: Prolapse, Vaginal
Post-Hysterectomy Vaginal Vault Prolapse
Vaginal Vault Prolapse

Interventions: Procedure: Intraperitoneal Uterosacral Ligament Suspension
Procedure: Extraperitoneal Uterosacral Ligament Suspension

First Posted Date: 2019-11-21

Last Posted Date: 2019-11-21

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 34

Registration Number: NCT04172896

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

7T MRI to Evaluate Cartilage Defects in the Knee

Completed

Conditions: Knee Pain Swelling
Knee Injuries
Arthropathy of Knee
Cartilage Damage
Cartilage Injury

Interventions: Diagnostic Test: 7 Tesla Magnetic Resonance Imaging Test

First Posted Date: 2019-10-07

Last Posted Date: 2023-03-16

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 112

Registration Number: NCT04118023

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Clinical Effectiveness of Pre-operative Methadone in Single Level Lateral Transpsoas Interbody Fusions

Phase 1

Conditions: Spondylolisthesis, Lumbar Region
Degenerative Disc Disease

Interventions: Drug: Methadone Hydrochloride
Drug: Oxycodone-Acetaminophen

First Posted Date: 2019-10-02

Last Posted Date: 2020-01-29

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 150

Registration Number: NCT04112550

An Injury Prevention Program for Professional Ballet

Not Applicable

Completed

Conditions: Injury Prevention
Accidents Sports

Interventions: Behavioral: Injury Prevention Program

First Posted Date: 2019-10-01

Last Posted Date: 2019-10-01

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 52

Registration Number: NCT04110002

Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer

Phase 2

Suspended

Conditions: Triple Negative Breast Cancer
Anthracycline-refractory TNBC

Interventions: Drug: Docetaxel
Drug: Pembrolizumab
Drug: IL-12 gene therapy

First Posted Date: 2019-09-19

Last Posted Date: 2024-02-21

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 30

Registration Number: NCT04095689

Locations: 🇺🇸
Houston Methodist Cancer Center, Houston, Texas, United States

T-regulatory Cells in ALS

Phase 2

Conditions: ALS (Amyotrophic Lateral Sclerosis)

Interventions: Biological: Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
Other: Monthly placebo infusions + 3 times per week placebo injections

First Posted Date: 2019-08-14

Last Posted Date: 2021-10-06

Lead Sponsor: The Methodist Hospital Research Institute

Target Recruit Count: 12

Registration Number: NCT04055623

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Massachusetts General Hospital Neurological Clinical Research Institute, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy